Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia (Annals of Hematology, (2020), 10.1007/s00277-020-04269-y)

Ke Wan; Yafei Yin; Zimian Luo; Jianzhao Cheng

ArticleOPEN ACCESS

Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia (Annals of Hematology, (2020), 10.1007/s00277-020-04269-y)

Annals of Hematology

DOI: 10.1007/s00277-020-04300-2

0Citations

5Readers

Abstract

The article “Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia”, written by Ke Wan, Yafei Yin, Zimian Luo and Jianzhao Cheng, was originally published online on September 17, 2020 with Open Access under a Creative Commons Attribution (CC BY) license 4.0. With the authors’ decision to cancel Open Access the copyright of the article changed on October 2020 to © Springer-Verlag GmbH Germany, part of Springer Nature 2020 with all rights reserved. The original article has been corrected.

Cite

CITATION STYLE

APA

Wan, K., Yin, Y., Luo, Z., & Cheng, J. (2021, January 1). Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia (Annals of Hematology, (2020), 10.1007/s00277-020-04269-y). Annals of Hematology. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00277-020-04300-2

Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia (Annals of Hematology, (2020), 10.1007/s00277-020-04269-y)

Abstract

Cite

Register to see more suggestions